1 results match your criteria Pharmaceutical Development and Regulation[Journal]

  • Page 1 of 1

Monitoring of Biomedical License Agreements: A Practical Guide.

Pharm Dev Regul 2003 Jan;1(3):191-203

US Department of Health and Human Services, National Institutes of Health, Office of Technology Transfer, Rockville, Maryland, USA.

Because technology licensed from research organizations can play a significant role in drug innovation and the generation of novel biomedical products, licensee performance under such agreements must be effectively monitored. This is necessary so that resultant benefits, including public health improvement, may be returned to the innovator(s) as well as society at large. The tasks that comprise monitoring are varied, but all come under the general heading of 'enforcement of license provisions'. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1901/jaba.2003.1-191DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787474PMC
January 2003
15 Reads
  • Page 1 of 1